Last reviewed · How we verify
NCT05123768: GenCP
Genetic Etiology in Patients With Cerebral Palsy
trial testing NGS in Cerebral Palsy in 150 participants. Completed in 1 November 2022.
1 July 2022
Quick facts
| Lead sponsor | University Medical Centre Ljubljana |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 April 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 November 2022 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- NGS — full drug profile →
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Genetic Disease — all drugs for Genetic Disease →
- Developmental Delay — all drugs for Developmental Delay →
- Metabolism, Inborn Errors — all drugs for Metabolism, Inborn Errors →
Sponsor
University Medical Centre Ljubljana
Who can join
Adults 5 to 25, any sex, with Cerebral Palsy or Genetic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cerebral palsy (CP) is a permanent disorder of movement or posture due to non-progressive impairments of the developing brain. Current estimates indicate that as many as 30% of CP cases may be genetic in nature. In our study, the investigators will re-examine the data of children with CP, who are registered in the Slovenian National Registry of Cerebral Palsy. All children will be invited to the University Children's Hospital, University Medical Centre Ljubljana, where they will be re-examined by a neurologist. Blood for genetic testing will be taken. In the case of confirmed genetic ethiology of CP, the search for specific therapy will be possible.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Unravelling genetic etiology of cerebral palsy: findings from a Slovenian pediatric cohort.
Arkar Silan U, Trebše A, Kovač J, Rogac M, et al · · 2025 · cited 1× · PMID 40771987 · DOI 10.3389/fneur.2025.1615449
Verify or expand the search:
- PubMed search for NCT05123768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NGS
Trials testing the same drug.
- NCT05476640 — Newborn Sequencing Screening in China · unknown
- NCT05216068 — Investigation and Diagnosis of the Chromosome Variation in Donated/abandoned Blastocyst · NA · completed
- NCT05076071 — Clinical Value of Next Generation Sequencing in Chinese Childhood Solid Tumors · unknown
- NCT04691414 — Retrospective Study Using Next Generation Sequencing (NGS) on Biological Samples to Improve Genetic Counseling for Patie · completed
- NCT03564704 — Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL · Phase 2, PHASE3 · unknown
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other University Medical Centre Ljubljana trials
Trials by the same sponsor.
- NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
- NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
- NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
- NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
- NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05123768 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
- Last refreshed: 2 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05123768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing